|
Volumn 108, Issue 23, 2003, Pages
|
The obsession with primary angioplasty.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DUTEPLASE;
RECOMBINANT PROTEIN;
TISSUE PLASMINOGEN ACTIVATOR;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HUMAN;
MORTALITY;
NOTE;
RECURRENT DISEASE;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIALS;
HUMANS;
MYOCARDIAL INFARCTION;
RECOMBINANT PROTEINS;
RECURRENCE;
THROMBOLYTIC THERAPY;
TISSUE PLASMINOGEN ACTIVATOR;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0642337776
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/01.cir.0000102947.33318.e8 Document Type: Note |
Times cited : (14)
|
References (0)
|